DK336188D0
(da)
*
|
1988-06-20 |
1988-06-20 |
Nordisk Gentofte |
Propeptider
|
US6875589B1
(en)
*
|
1988-06-23 |
2005-04-05 |
Hoechst Aktiengesellschaft |
Mini-proinsulin, its preparation and use
|
US5514646A
(en)
*
|
1989-02-09 |
1996-05-07 |
Chance; Ronald E. |
Insulin analogs modified at position 29 of the B chain
|
US5126249A
(en)
*
|
1989-05-09 |
1992-06-30 |
Eli Lilly And Company |
Enzymatic removal of a protein amino-terminal sequence
|
DK155690D0
(da)
*
|
1990-06-28 |
1990-06-28 |
Novo Nordisk As |
Nye peptider
|
DK10191D0
(da)
*
|
1991-01-22 |
1991-01-22 |
Novo Nordisk As |
Hidtil ukendte peptider
|
US5304473A
(en)
*
|
1991-06-11 |
1994-04-19 |
Eli Lilly And Company |
A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production
|
DK72793D0
(da)
*
|
1993-06-21 |
1993-06-21 |
Novo Nordisk As |
Nyt produkt
|
US6869930B1
(en)
*
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
US5461031A
(en)
*
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
US5474978A
(en)
*
|
1994-06-16 |
1995-12-12 |
Eli Lilly And Company |
Insulin analog formulations
|
US5504188A
(en)
*
|
1994-06-16 |
1996-04-02 |
Eli Lilly And Company |
Preparation of stable zinc insulin analog crystals
|
US5547929A
(en)
*
|
1994-09-12 |
1996-08-20 |
Eli Lilly And Company |
Insulin analog formulations
|
AU3562195A
(en)
*
|
1994-10-04 |
1996-04-26 |
Novo Nordisk A/S |
Preparations containing aspb28 human insulin and nicotinamide
|
US5597893A
(en)
*
|
1994-10-31 |
1997-01-28 |
Eli Lilly And Company |
Preparation of stable insulin analog crystals
|
US5631347A
(en)
*
|
1995-06-07 |
1997-05-20 |
Eli Lilly And Company |
Reducing gelation of a fatty acid-acylated protein
|
CN1069649C
(zh)
*
|
1996-01-25 |
2001-08-15 |
中国科学院上海生物化学研究所 |
[b9谷氨酸,b10门冬氨酸]人胰岛素
|
US5948751A
(en)
*
|
1996-06-20 |
1999-09-07 |
Novo Nordisk A/S |
X14-mannitol
|
DE19726167B4
(de)
*
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
CN1276731A
(zh)
|
1997-10-24 |
2000-12-13 |
伊莱利利公司 |
不溶性胰岛素组合物
|
EP1030688B1
(de)
*
|
1997-11-12 |
2004-09-29 |
Alza Corporation |
Verfahren zur dermalen verabreichung von polypeptiden
|
CO4970787A1
(es)
*
|
1997-12-23 |
2000-11-07 |
Lilly Co Eli |
Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
|
US6933272B1
(en)
|
1998-09-22 |
2005-08-23 |
Erik Helmerhorst |
Use of non-peptidyl compounds for the treatment of insulin related ailments
|
AUPP609198A0
(en)
*
|
1998-09-22 |
1998-10-15 |
Curtin University Of Technology |
Use of non-peptidyl compounds for the treatment of insulin related ailments
|
US7169889B1
(en)
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
US7022674B2
(en)
*
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
ES2266187T3
(es)
|
2000-03-24 |
2007-03-01 |
Genentech, Inc. |
Uso de la insulina para el tratamiento de trastornos del cartilago.
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US6867183B2
(en)
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7202059B2
(en)
|
2001-02-20 |
2007-04-10 |
Sanofi-Aventis Deutschland Gmbh |
Fusion proteins capable of being secreted into a fermentation medium
|
US7638618B2
(en)
|
2001-02-20 |
2009-12-29 |
Sanofi-Aventis Deutschland Gmbh |
Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
|
AU2002248464A1
(en)
*
|
2001-02-21 |
2002-09-12 |
Medtronic Minimed, Inc. |
Stabilized insulin formulations
|
DE10114178A1
(de)
|
2001-03-23 |
2002-10-10 |
Aventis Pharma Gmbh |
Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
|
US6713452B2
(en)
*
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7713932B2
(en)
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828305B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
US6913903B2
(en)
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7196059B2
(en)
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7030082B2
(en)
*
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
US7312192B2
(en)
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7166571B2
(en)
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
AU2003236521A1
(en)
*
|
2002-06-13 |
2003-12-31 |
Nobex Corporation |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
DE10227232A1
(de)
|
2002-06-18 |
2004-01-15 |
Aventis Pharma Deutschland Gmbh |
Saure Insulinzubereitungen mit verbesserter Stabilität
|
CN1247616C
(zh)
*
|
2002-07-19 |
2006-03-29 |
上海中科生龙达生物技术(集团)有限公司 |
新的单体胰岛素,药物组合物及其制法
|
US7193035B2
(en)
|
2002-10-29 |
2007-03-20 |
Sanofi-Aventis Deutschland Gmbh |
Crystals of insulin analogs and processes for their preparation
|
EA014887B1
(ru)
|
2003-06-17 |
2011-02-28 |
Сембайосиз Джинетикс Инк. |
Способ экспрессии инсулина в семенах растения, способ получения семян растений, содержащих инсулин, и растения, способные производить семена, содержащие инсулин
|
PT2275439E
(pt)
|
2003-08-05 |
2014-06-25 |
Novo Nordisk As |
Novos derivados de insulina
|
BRPI0413276B8
(pt)
|
2003-08-05 |
2021-05-25 |
Novo Nordisk As |
derivado de insulina, complexo de zinco do mesmo, e, composição farmacêutica
|
KR101243648B1
(ko)
|
2003-11-20 |
2013-03-14 |
노보 노르디스크 에이/에스 |
제조 및 주사 장치용에 최적인 프로필렌 글리콜 함유펩티드 제제
|
WO2005054291A1
(en)
|
2003-12-03 |
2005-06-16 |
Novo Nordisk A/S |
Single-chain insulin
|
EP2368579A1
(de)
|
2004-01-21 |
2011-09-28 |
Novo Nordisk Health Care AG |
Tranglutaminase vermittelte konjugation von peptiden.
|
EP2626368B1
(de)
|
2004-07-19 |
2016-12-21 |
Biocon Limited |
Insulinoligomerkonjugate, Formulierungen und Verwendungen davon
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
WO2006082205A1
(en)
|
2005-02-02 |
2006-08-10 |
Novo Nordisk A/S |
Insulin derivatives
|
ES2428510T3
(es)
|
2005-02-02 |
2013-11-08 |
Novo Nordisk A/S |
Derivados de insulina
|
WO2006093222A1
(ja)
*
|
2005-03-02 |
2006-09-08 |
Ajinomoto Co., Inc. |
インスリンの多量体形成阻害剤
|
ES2368500T3
(es)
|
2005-08-16 |
2011-11-17 |
Novo Nordisk A/S |
Método para producir polipéptidos de insulina maduros.
|
PT1926749E
(pt)
|
2005-09-14 |
2011-09-29 |
Sanofi Aventis Deutschland |
Clivagem de precursores de insulinas por uma variante de tripsina
|
ES2371361T3
(es)
|
2005-12-28 |
2011-12-30 |
Novo Nordisk A/S |
Composiciones que comprenden una insulina acilada y zinc y método de producción de dichas composiciones.
|
ATE482977T1
(de)
|
2006-02-27 |
2010-10-15 |
Novo Nordisk As |
Insulinderivate
|
US20090054305A1
(en)
|
2006-03-15 |
2009-02-26 |
Novo Nordisk A/S |
Mixtures of Amylin and Insulin
|
KR101441444B1
(ko)
|
2006-05-09 |
2014-09-18 |
노보 노르디스크 에이/에스 |
인슐린 유도체
|
US8796205B2
(en)
|
2006-05-09 |
2014-08-05 |
Novo Nordisk A/S |
Insulin derivative
|
US20090099064A1
(en)
*
|
2006-06-08 |
2009-04-16 |
Diabecore Medical Inc., |
Derivatized insulin oligomers
|
CN101541830A
(zh)
|
2006-09-22 |
2009-09-23 |
诺沃-诺迪斯克有限公司 |
蛋白酶抗性的胰岛素类似物
|
WO2008132224A2
(en)
|
2007-04-30 |
2008-11-06 |
Novo Nordisk A/S |
Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
|
JP2011504871A
(ja)
|
2007-06-01 |
2011-02-17 |
ノボ・ノルデイスク・エー/エス |
固体又は半固体担体中にペプチド薬剤を含む自然に分散可能なプレコンセントレイト
|
CN101677944A
(zh)
|
2007-06-01 |
2010-03-24 |
诺沃-诺迪斯克有限公司 |
稳定的非含水药物组合物
|
EP2167032B1
(de)
|
2007-06-13 |
2019-08-07 |
Novo Nordisk A/S |
Pharmazeutische formulierung enthaltend ein insulinderivat
|
AU2008313248B2
(en)
|
2007-10-16 |
2012-04-26 |
Biocon Limited |
An orally administerable solid pharmaceutical composition and a process thereof
|
NZ603812A
(en)
|
2007-11-20 |
2014-06-27 |
Ambrx Inc |
Modified insulin polypeptides and their uses
|
CA2711749A1
(en)
|
2008-01-09 |
2009-07-16 |
Sanofi-Aventis Deutschland Gmbh |
Novel insulin derivatives having an extremely delayed time-action profile
|
WO2009112583A2
(en)
|
2008-03-14 |
2009-09-17 |
Novo Nordisk A/S |
Protease-stabilized insulin analogues
|
EP2910571B1
(de)
|
2008-03-18 |
2016-10-05 |
Novo Nordisk A/S |
Proteasestabilisierte, acylierte insulinanaloga
|
DE102008053048A1
(de)
|
2008-10-24 |
2010-04-29 |
Sanofi-Aventis Deutschland Gmbh |
Kombination von einem Insulin und einem GLP-1-Agonisten
|
RS56632B1
(sr)
|
2008-10-17 |
2018-03-30 |
Sanofi Aventis Deutschland |
Kombinacija insulina i glp-1-agonista
|
DE102009038210A1
(de)
|
2009-08-20 |
2011-03-03 |
Sanofi-Aventis Deutschland Gmbh |
Kombination von einem Insulin und einem GLP-1-Agonisten
|
DE102008051834A1
(de)
|
2008-10-17 |
2010-04-22 |
Sanofi-Aventis Deutschland Gmbh |
Kombination von einem Insulin und einem GLP-1-Agonisten
|
BRPI0919946A2
(pt)
|
2008-10-30 |
2016-02-16 |
Novo Nordisk As |
tratamento de diabetes melito usando injeções de insulina com frequência de injeção menor que diariamente
|
TW201105346A
(en)
*
|
2009-07-06 |
2011-02-16 |
Sanofi Aventis Deutschland |
Heat-stable and vibration-stable insulin preparations
|
SG177567A1
(en)
|
2009-07-06 |
2012-02-28 |
Sanofi Aventis Deutschland |
Aqueous insulin preparations containing methionine
|
EP2451471A1
(de)
|
2009-07-06 |
2012-05-16 |
Sanofi-Aventis Deutschland GmbH |
Langsamwirkende insulinzubereitungen
|
WO2011012718A1
(en)
|
2009-07-31 |
2011-02-03 |
Ascendis Pharma As |
Prodrugs comprising an insulin linker conjugate
|
BR112012001988A2
(pt)
|
2009-07-31 |
2017-05-09 |
Sanofi Aventis Deutschland |
composição de insulina de ação prolongada
|
CN102711804B
(zh)
|
2009-11-13 |
2015-09-16 |
赛诺菲-安万特德国有限公司 |
包含glp-1激动剂和甲硫氨酸的药物组合物
|
AU2010317995B2
(en)
|
2009-11-13 |
2014-04-17 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine
|
CA2795091A1
(en)
|
2010-05-10 |
2011-11-17 |
Novo Nordisk A/S |
Process for the preparation of insulin-zinc complexes
|
MY162837A
(en)
|
2010-08-17 |
2017-07-31 |
Ambrx Inc |
Modified relaxin polypeptides and their uses
|
JP6199186B2
(ja)
|
2010-08-30 |
2017-09-20 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
2型糖尿病の治療用の医薬の製造のためのave0010の使用
|
EP2438930A1
(de)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Prodrug mit einem exendinbindenden Konjugat
|
RU2013123515A
(ru)
|
2010-10-27 |
2014-12-10 |
Ново Нордиск А/С |
Лечение сахарного диабета с помощью инъекций инсулина, вводимых с различными интервалами
|
PL2632478T3
(pl)
|
2010-10-27 |
2020-03-31 |
Novo Nordisk A/S |
Leczenie cukrzycy z zastosowaniem zastrzyków insuliny podawanych w różnych odstępach czasu
|
US9821032B2
(en)
|
2011-05-13 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
|
JP6367115B2
(ja)
|
2011-08-29 |
2018-08-01 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
2型糖尿病患者の血糖コントロールに使用する組合せ医薬
|
TWI559929B
(en)
|
2011-09-01 |
2016-12-01 |
Sanofi Aventis Deutschland |
Pharmaceutical composition for use in the treatment of a neurodegenerative disease
|
RU2014127270A
(ru)
|
2011-12-15 |
2016-02-10 |
Шанхай Хэнжуй Фармасьютикал Ко., Лтд. |
Аналог человеческого инсулина и его ацилированное производное
|
AU2013255880B2
(en)
|
2012-05-01 |
2017-07-20 |
Novo Nordisk A/S |
Pharmaceutical composition
|
US20130315891A1
(en)
|
2012-05-25 |
2013-11-28 |
Matthew Charles |
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
|
HUE032613T2
(en)
|
2012-06-04 |
2017-10-30 |
Diamedica Therapeutics Inc |
Human tissue kallikrein 1 is glycosylated isoforms
|
CN104902922B
(zh)
|
2012-11-13 |
2017-12-12 |
阿道恰公司 |
包含经取代阴离子化合物的速效胰岛素制剂
|
US9867869B2
(en)
|
2012-12-12 |
2018-01-16 |
Massachusetts Institute Of Technology |
Insulin derivatives for diabetes treatment
|
WO2014096985A2
(en)
|
2012-12-19 |
2014-06-26 |
Wockhardt Limited |
A stable aqueous composition comprising human insulin or an analogue or derivative thereof
|
JP2016505601A
(ja)
|
2012-12-26 |
2016-02-25 |
ウォックハート リミテッド |
医薬組成物
|
KR20140088837A
(ko)
*
|
2013-01-03 |
2014-07-11 |
한미약품 주식회사 |
N-말단 전하가 변형된 인슐린 분비 펩티드 유도체
|
TWI780236B
(zh)
|
2013-02-04 |
2022-10-11 |
法商賽諾菲公司 |
胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
|
US10137172B2
(en)
|
2013-04-30 |
2018-11-27 |
Novo Nordisk A/S |
Administration regime
|
SG11201601477VA
(en)
|
2013-09-30 |
2016-04-28 |
Wockhardt Ltd |
Pharmaceutical composition
|
ES2676065T3
(es)
|
2013-10-07 |
2018-07-16 |
Novo Nordisk A/S |
Nuevo derivado de un análogo de la insulina
|
CN112957455A
(zh)
|
2014-01-09 |
2021-06-15 |
赛诺菲 |
胰岛素类似物和/或胰岛素衍生物的稳定化药物制剂
|
MX2016008978A
(es)
|
2014-01-09 |
2016-10-04 |
Sanofi Sa |
Formulaciones farmaceuticas de analogos de insulina y/o derivados de insulina estabilizadas y que estan libres de glicerol.
|
CN105899190B
(zh)
|
2014-01-09 |
2022-06-14 |
赛诺菲 |
门冬胰岛素的稳定化药物制剂
|
AR099569A1
(es)
*
|
2014-02-28 |
2016-08-03 |
Novo Nordisk As |
Derivados de insulina y los usos médicos de estos
|
CN104017809A
(zh)
*
|
2014-06-05 |
2014-09-03 |
山东省农业科学院生物技术研究中心 |
改造的人Insulin蛋白表达基因及表达方法
|
WO2016001862A1
(en)
|
2014-07-04 |
2016-01-07 |
Wockhardt Limited |
Extended release formulations of insulins
|
MX2017007699A
(es)
|
2014-12-12 |
2017-09-18 |
Sanofi Aventis Deutschland |
Formulacion de proporcion fija de insulina glargina/lixisenatida.
|
AR102869A1
(es)
|
2014-12-16 |
2017-03-29 |
Lilly Co Eli |
Composiciones de insulina de rápida acción
|
TWI748945B
(zh)
|
2015-03-13 |
2021-12-11 |
德商賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患治療
|
TW201705975A
(zh)
|
2015-03-18 |
2017-02-16 |
賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患之治療
|
JO3749B1
(ar)
|
2015-08-27 |
2021-01-31 |
Lilly Co Eli |
تركيبات إنسولين سريعة المفعول
|
UY36870A
(es)
*
|
2015-08-28 |
2017-03-31 |
Hanmi Pharm Ind Co Ltd |
Análogos de insulina novedosos
|
CN105440125B
(zh)
*
|
2015-11-25 |
2019-09-24 |
华润昂德生物药业有限公司 |
地特胰岛素或其类似物的制备方法
|
GB201607918D0
(en)
|
2016-05-06 |
2016-06-22 |
Arecor Ltd |
Novel formulations
|
KR20180033105A
(ko)
|
2016-09-23 |
2018-04-02 |
한미약품 주식회사 |
인슐린 수용체와의 결합력이 감소된, 인슐린 아날로그 및 이의 용도
|
EP3518893A1
(de)
|
2016-09-29 |
2019-08-07 |
Arecor Limited |
Neuartige formulierungen
|
MA49116A
(fr)
|
2016-12-16 |
2020-03-25 |
Novo Nordisk As |
Compositions pharmaceutiques contenant de l'insuline
|
AU2018230478A1
(en)
|
2017-03-09 |
2019-09-12 |
Diamedica Inc. |
Dosage forms of tissue kallikrein 1
|
AU2018239037B2
(en)
|
2017-03-23 |
2022-05-26 |
Hanmi Pharm. Co., Ltd. |
Insulin analog complex with reduced affinity for insulin receptor and use thereof
|
GB201707188D0
(en)
|
2017-05-05 |
2017-06-21 |
Arecor Ltd |
Novel formulations
|
GB201707187D0
(en)
|
2017-05-05 |
2017-06-21 |
Arecor Ltd |
Novel formulations
|
GB201707189D0
(en)
|
2017-05-05 |
2017-06-21 |
Arecor Ltd |
Novel formulations
|
AU2018275545B2
(en)
|
2017-06-01 |
2021-02-04 |
Eli Lilly And Company |
Rapid-acting insulin compositions
|
WO2019193353A1
(en)
|
2018-04-04 |
2019-10-10 |
Arecor Limited |
Medical infusion pump system for the delivery of an insulin compound
|
KR20200139700A
(ko)
|
2018-04-04 |
2020-12-14 |
아레콜 리미티드 |
인슐린 화합물의 전달을 위한 의료용 주입 펌프 시스템
|
US20210113763A1
(en)
|
2018-04-04 |
2021-04-22 |
Arecor Limited |
Medical infusion pump system for the delivery of an insulin compound
|
CN111601819A
(zh)
|
2018-05-24 |
2020-08-28 |
江苏恒瑞医药股份有限公司 |
一种重组人胰岛素或其类似物的前体的制备方法
|
US10335464B1
(en)
|
2018-06-26 |
2019-07-02 |
Novo Nordisk A/S |
Device for titrating basal insulin
|
MX2022008139A
(es)
|
2019-12-30 |
2022-10-03 |
Gan & Lee Pharmaceuticals Co Ltd |
Compuestos de glp-1 de acción prolongada.
|
MX2022008130A
(es)
|
2019-12-30 |
2022-10-03 |
Gan & Lee Pharmaceuticals Co Ltd |
Derivado de insulina.
|
GB202004814D0
(en)
|
2020-04-01 |
2020-05-13 |
Arecor Ltd |
Novel formulations
|
CN114075275A
(zh)
*
|
2020-08-17 |
2022-02-22 |
成都奥达生物科技有限公司 |
一种长效胰岛素类似物
|
CN115493919B
(zh)
*
|
2022-11-21 |
2023-04-07 |
保定佳瑞源生物芯片有限公司 |
一种c肽和胰岛素检测试剂盒的校准品稀释液
|